Peers

Deccan Health Care Ltd. shows promising growth metrics, but it significantly trails its peers in profitability and efficiency. Companies like Cipla and Dr. Reddy's are standout performers, while Deccan remains a potential growth pick despite its high valuation. The sector displays a mix of strong performers and some financially weaker entities, highlighting opportunities and risks for investors.

• • Deccan Health Care Ltd. has strong revenue growth but low profitability metrics when compared to peers.
• • Cipla Ltd. and Dr. Reddy's Laboratories Ltd. lead in profitability and efficiency metrics.
• • Divi's Laboratories and Sun Pharmaceutical are among the more expensive stocks based on valuation metrics.

• • Cipla Ltd.: Strong profitability metrics with a low PE ratio, indicating good value for growth.
• • Dr. Reddy's Laboratories Ltd.: Excellent ROE and ROCE, coupled with strong revenue growth.
• • Mankind Pharma Ltd.: High growth rates in revenue and EPS, along with solid profitability.